|
1AXC
HUMAN PCNA
Deposited 1997-10-14
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.60 Å
R-free 0.289
|
|
1U76
Crystal structure of hPCNA bound to residues 452-466 of the DNA polymerase-delta-p66 subunit
Deposited 2004-08-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;ammonium sulfate, sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.60 Å
R-free 0.278
|
|
1U7B
Crystal structure of hPCNA bound to residues 331-350 of the flap endonuclease-1 (FEN1)
Deposited 2004-08-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;ammonium sulfate, sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 1.88 Å
R-free 0.265
|
|
1UL1
Crystal structure of the human FEN1-PCNA complex
Deposited 2003-09-05
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;283 K;6% PEG1000, 50mM MES, 50mM Sodium chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 283K
|
Resolution 2.90 Å
R-free 0.284
|
|
1VYJ
Structural and biochemical studies of human PCNA complexes provide the basis for association with CDK/cyclin and rationale for inhibitor design
Deposited 2004-04-30
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;2.7M AS, HEPES PH8, pH 8.00
|
Resolution 2.80 Å
R-free 0.256
|
|
1VYJ
Structural and biochemical studies of human PCNA complexes provide the basis for association with CDK/cyclin and rationale for inhibitor design
Deposited 2004-04-30
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain G
1–261(261 aa)
Chain I
1–261(261 aa)
Chain K
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;2.7M AS, HEPES PH8, pH 8.00
|
Resolution 2.80 Å
R-free 0.256
|
|
1VYM
NATIVE HUMAN PCNA
Deposited 2004-05-03
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;20% PEG3350, 0.2M MAGNESIUM ACETATE, pH 7.00
|
Resolution 2.30 Å
R-free 0.279
|
|
1W60
NATIVE HUMAN PCNA
Deposited 2004-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;35% PEGMME 2K, 0.1M NA ACETATE (PH4.6), 0.2M AS., pH 4.60
|
Resolution 3.15 Å
R-free 0.278
|
|
1W60
NATIVE HUMAN PCNA
Deposited 2004-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;35% PEGMME 2K, 0.1M NA ACETATE (PH4.6), 0.2M AS., pH 4.60
|
Resolution 3.15 Å
R-free 0.278
|
|
2ZVK
Crystal structure of PCNA in complex with DNA polymerase eta fragment
Deposited 2008-11-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 3.6;293 K;pH3.6, HANGING DROP VAPOR DIFFUSION, temperature 293K
|
Resolution 2.70 Å
R-free 0.286
|
|
2ZVL
Crystal structure of PCNA in complex with DNA polymerase kappa fragment
Deposited 2008-11-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
HANGING DROP VAPOR DIFFUSION;pH 5.2;293 K;pH5.2, HANGING DROP VAPOR DIFFUSION, temperature 293K
|
Resolution 2.50 Å
R-free 0.289
|
|
2ZVL
Crystal structure of PCNA in complex with DNA polymerase kappa fragment
Deposited 2008-11-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
1–261(261 aa)
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
HANGING DROP VAPOR DIFFUSION;pH 5.2;293 K;pH5.2, HANGING DROP VAPOR DIFFUSION, temperature 293K
|
Resolution 2.50 Å
R-free 0.289
|
|
2ZVM
Crystal structure of PCNA in complex with DNA polymerase iota fragment
Deposited 2008-11-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
HANGING DROP VAPOR DIFFUSION;pH 6.4;293 K;pH6.4, HANGING DROP VAPOR DIFFUSION, temperature 293K
|
Resolution 2.30 Å
R-free 0.251
|
|
3JA9
Structure of native human PCNA
Deposited 2015-05-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8;50mM Tris-HCl, 5mM MgCl2
|
Resolution 22.00 Å
|
|
3P87
Structure of human PCNA bound to RNASEH2B PIP box peptide
Deposited 2010-10-13
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 3.5;293.15 K;3M NaCl, 0.1M citrate, pH 3.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 2.99 Å
R-free 0.248
|
|
3P87
Structure of human PCNA bound to RNASEH2B PIP box peptide
Deposited 2010-10-13
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain D
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 3.5;293.15 K;3M NaCl, 0.1M citrate, pH 3.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 2.99 Å
R-free 0.248
|
|
3P87
Structure of human PCNA bound to RNASEH2B PIP box peptide
Deposited 2010-10-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 3.5;293.15 K;3M NaCl, 0.1M citrate, pH 3.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 2.99 Å
R-free 0.248
|
|
3TBL
Structure of Mono-ubiquitinated PCNA: Implications for DNA Polymerase Switching and Okazaki Fragment Maturation
Deposited 2011-08-07
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;288 K;0.9 to 1.3 M sodium citrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.90 Å
R-free 0.293
|
|
3VKX
Structure of PCNA
Deposited 2011-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
|
Not recorded
|
T3 3,5,3'TRIIODOTHYRONINE × 3
SO4 SULFATE ION × 18
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.10 Å
R-free 0.249
|
|
3WGW
Structure of PCNA bound to a small molecule inhibitor
Deposited 2013-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
|
Not recorded
|
T2B 4-{4-[(2S)-2-amino-3-hydroxypropyl]-2,6-diiodophenoxy}phenol × 6
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.221
|
|
3WGW
Structure of PCNA bound to a small molecule inhibitor
Deposited 2013-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–261(261 aa)
|
Not recorded
|
T2B 4-{4-[(2S)-2-amino-3-hydroxypropyl]-2,6-diiodophenoxy}phenol × 3
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.221
|
|
4D2G
Crystal structure of human PCNA in complex with p15 peptide
Deposited 2014-05-09
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
40% PEG 300 IN 0.1 MM PHOSPHATE-CITRATE PH 4.2
|
Resolution 2.65 Å
R-free 0.250
|
|
4RJF
Crystal structure of the human sliding clamp at 2.0 angstrom resolution
Deposited 2014-10-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.08M strontium chloride hexahydrate, 0.02M magnesium chloride hexahydrate, 0.04M sodium cacodylate trihydrate (pH7.0), 20% v/v (+/-)-2-methyl-2,4-pentanediol and 0.012M spermine tetrahydrochloride, final [PCNA] = 11.6mg/mL = 0.40mM, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.01 Å
R-free 0.189
|
|
4RJF
Crystal structure of the human sliding clamp at 2.0 angstrom resolution
Deposited 2014-10-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.08M strontium chloride hexahydrate, 0.02M magnesium chloride hexahydrate, 0.04M sodium cacodylate trihydrate (pH7.0), 20% v/v (+/-)-2-methyl-2,4-pentanediol and 0.012M spermine tetrahydrochloride, final [PCNA] = 11.6mg/mL = 0.40mM, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.01 Å
R-free 0.189
|
|
4RJF
Crystal structure of the human sliding clamp at 2.0 angstrom resolution
Deposited 2014-10-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.08M strontium chloride hexahydrate, 0.02M magnesium chloride hexahydrate, 0.04M sodium cacodylate trihydrate (pH7.0), 20% v/v (+/-)-2-methyl-2,4-pentanediol and 0.012M spermine tetrahydrochloride, final [PCNA] = 11.6mg/mL = 0.40mM, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
Resolution 2.01 Å
R-free 0.189
|
|
4ZTD
Crystal Structure of Human PCNA in complex with a TRAIP peptide
Deposited 2015-05-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
2–254(253 aa)
Fragment:UNP residues 2-254
Chain B
2–254(253 aa)
Fragment:UNP residues 2-254
Chain C
2–254(253 aa)
Fragment:UNP residues 2-254
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;16% PEG 6K in 0.1mM magnesium acetate, MES buffer pH 6.5
|
Resolution 2.20 Å
R-free 0.234
|
|
5E0T
Human PCNA mutant - S228I
Deposited 2015-09-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Mutation:S228I
Mutation:S228I
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;100mM sodium acetate, pH4.5, 2M ammonium sulfate
|
Resolution 2.67 Å
R-free 0.226
|
|
5E0T
Human PCNA mutant - S228I
Deposited 2015-09-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Mutation:S228I
Mutation:S228I
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;100mM sodium acetate, pH4.5, 2M ammonium sulfate
|
Resolution 2.67 Å
R-free 0.226
|
|
5E0U
Human PCNA variant (S228I) complexed with p21 at 1.9 Angstroms
Deposited 2015-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–261(261 aa)
|
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;100mM HEPES pH 7.5, 25% PEG 3350
|
Resolution 1.93 Å
R-free 0.221
|
|
5E0U
Human PCNA variant (S228I) complexed with p21 at 1.9 Angstroms
Deposited 2015-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–261(261 aa)
|
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;100mM HEPES pH 7.5, 25% PEG 3350
|
Resolution 1.93 Å
R-free 0.221
|
|
5E0U
Human PCNA variant (S228I) complexed with p21 at 1.9 Angstroms
Deposited 2015-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–261(261 aa)
|
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;100mM HEPES pH 7.5, 25% PEG 3350
|
Resolution 1.93 Å
R-free 0.221
|
|
5E0V
Human PCNA variant (S228I) complexed with FEN1 at 2.1 Angstroms
Deposited 2015-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–261(261 aa)
|
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;2.35 M ammonium sulfate, 100 mM sodium acetate pH 4.6, 40% (v/v) -1,3-Butanediol
|
Resolution 2.07 Å
R-free 0.229
|
|
5E0V
Human PCNA variant (S228I) complexed with FEN1 at 2.1 Angstroms
Deposited 2015-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–261(261 aa)
|
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;2.35 M ammonium sulfate, 100 mM sodium acetate pH 4.6, 40% (v/v) -1,3-Butanediol
|
Resolution 2.07 Å
R-free 0.229
|
|
5IY4
Crystal structure of human PCNA in complex with the PIP box of DVC1
Deposited 2016-03-24
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;289 K;0.1 M Sodium citrate tribasic dehydrates (pH 5.0), 30% v/v Jeffamine ED-2001 (pH 7.0)
|
Resolution 2.94 Å
R-free 0.270
|
|
5MAV
Crystal structure of human PCNA in complex with PARG (poly(ADP-ribose) glycohydrolase) peptide.
Deposited 2016-11-06
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295.15 K;0.1 M Tris-HCl pH 7.5, 20% PEG 3350, 0.2 M ammonium acetate
|
Resolution 2.58 Å
R-free 0.291
|
|
5MAV
Crystal structure of human PCNA in complex with PARG (poly(ADP-ribose) glycohydrolase) peptide.
Deposited 2016-11-06
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain D
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295.15 K;0.1 M Tris-HCl pH 7.5, 20% PEG 3350, 0.2 M ammonium acetate
|
Resolution 2.58 Å
R-free 0.291
|
|
5MLO
Crystal structure of human PCNA in complex with ZRANB3 PIP box peptide
Deposited 2016-12-07
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;100 mM NaCl + 8% (v/v) DMSO + 31% pentaerythitol propoxylate (5/4 PO/OH)
|
Resolution 1.96 Å
R-free 0.259
|
|
5MLW
Crystal structure of human PCNA in complex with ZRANB3 APIM motif peptide
Deposited 2016-12-07
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;100 mM lithium sulfate + 30% (w/v) polyvinylpyrrolidone + 100 mM HEPES pH 7.0
|
Resolution 2.45 Å
R-free 0.264
|
|
5MOM
Crystal Structure of PCNA encoding the hypomorphic mutation S228I
Deposited 2016-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–258(258 aa)
Chain B
1–258(258 aa)
Chain C
1–258(258 aa)
|
Mutation:S228I
Mutation:S228I
Mutation:S228I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;0.1M NaAcO, 2M (NH4)2SO4
|
Resolution 2.27 Å
R-free 0.216
|
|
5YCO
Complex structure of PCNA with UHRF2
Deposited 2017-09-07
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
GOL GLYCEROL × 3
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2 M ammonium sulfate, 0.1 M Tris pH 8.0
|
Resolution 2.20 Å
R-free 0.220
|
|
5YCO
Complex structure of PCNA with UHRF2
Deposited 2017-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–261(261 aa)
|
Not recorded
|
GOL GLYCEROL × 3
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2 M ammonium sulfate, 0.1 M Tris pH 8.0
|
Resolution 2.20 Å
R-free 0.220
|
|
5YD8
Crystal structure of human PCNA in complex with APIM of human ZRANB3
Deposited 2017-09-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain Y
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG 3350
|
Resolution 2.30 Å
R-free 0.265
|
|
5YD8
Crystal structure of human PCNA in complex with APIM of human ZRANB3
Deposited 2017-09-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain X
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG 3350
|
Resolution 2.30 Å
R-free 0.265
|
|
5YD8
Crystal structure of human PCNA in complex with APIM of human ZRANB3
Deposited 2017-09-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain Z
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG 3350
|
Resolution 2.30 Å
R-free 0.265
|
|
6CBI
PCNA in complex with inhibitor
Deposited 2018-02-03
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;289 K;2M ammonium sulfate
0.1M Tris pH8.0
|
Resolution 2.75 Å
R-free 0.252
|
|
6CBI
PCNA in complex with inhibitor
Deposited 2018-02-03
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–261(261 aa)
Chain D
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;289 K;2M ammonium sulfate
0.1M Tris pH8.0
|
Resolution 2.75 Å
R-free 0.252
|
|
6EHT
Modulation of PCNA sliding surface by p15PAF suggests a suppressive mechanism for cisplatin-induced DNA lesion bypass by pol eta holoenzyme
Deposited 2017-09-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 5
PDB declaration: heptameric
|
Chain A
1–254(254 aa)
Chain B
1–254(254 aa)
Chain C
1–255(255 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;10% polyethylene glycol 3350
0.1 M sodium acetate pH 4.5
|
Resolution 3.20 Å
R-free 0.327
|
|
6FCM
Crystal structure of human PCNA
Deposited 2017-12-20
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;19 to 23% PEG 3350, 0.2 to 0.3 M NaCl, 0.1 M Tris-HCl pH 8.5
|
Resolution 2.80 Å
R-free 0.276
|
|
6FCN
Crystal structure of human PCNA soaked with p47phox(106-127) peptide
Deposited 2017-12-20
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;19 to 23% PEG 3350, 0.2 to 0.3 M NaCl, 0.1 M Tris-HCl pH 8.5
12h prior to crystal freezing, 100 uM of p47phox(106-127) peptide was added to the crystallization drop
|
Resolution 3.22 Å
R-free 0.272
|
|
6GIS
Structural basis of human clamp sliding on DNA
Deposited 2018-05-15
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 3
PDB declaration: pentameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Mutation:H from His tag
Mutation:H from His tag
Mutation:H from His tag
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;11% PEG 3350
0.1M Sodium acetate ph 4.5
|
Resolution 2.82 Å
R-free 0.284
|
|
6GWS
Crystal structure of human PCNA in complex with three p15 peptides
Deposited 2018-06-25
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;28% PEG 400, 0.2 M CaCl2, 0.1 M Hepes
|
Resolution 2.90 Å
R-free 0.263
|
|
6HVO
Crystal structure of human PCNA in complex with three peptides of p12 subunit of human polymerase delta
Deposited 2018-10-11
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;Bis Tris 6.5 , Li2SO4 (0.2M), PEG 3350 24%
|
Resolution 2.10 Å
R-free 0.244
|
|
6K3A
Crystal structure of human PCNA in complex with DNMT1 PIP box motif.
Deposited 2019-05-17
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;1.6M sodium citrate
|
Resolution 2.30 Å
R-free 0.264
|
|
6QC0
PCNA complex with Cdt2 C-terminal PIP-box peptide
Deposited 2018-12-25
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;10% (w/v) PEG 6000
100 mM MES/HCl
|
Resolution 3.50 Å
R-free 0.252
|
|
6QCG
PCNA complex with Cdt1 N-terminal PIP-box peptide
Deposited 2018-12-28
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;300 K;15% (w/v) PEG 400, 100 mM calcium acetate, 100 mM MES/HCl
|
Resolution 3.40 Å
R-free 0.253
|
|
6QCG
PCNA complex with Cdt1 N-terminal PIP-box peptide
Deposited 2018-12-28
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
1–261(261 aa)
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;300 K;15% (w/v) PEG 400, 100 mM calcium acetate, 100 mM MES/HCl
|
Resolution 3.40 Å
R-free 0.253
|
|
6S1M
Human polymerase delta holoenzyme Conformer 1
Deposited 2019-06-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 7
PDB declaration: nonameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
ZN ZINC ION × 1
SF4 IRON/SULFUR CLUSTER × 1
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.27 Å
|
|
6S1N
Human polymerase delta holoenzyme Conformer 2
Deposited 2019-06-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 7
PDB declaration: nonameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
ZN ZINC ION × 1
SF4 IRON/SULFUR CLUSTER × 1
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.86 Å
|
|
6S1O
Human polymerase delta holoenzyme Conformer 3
Deposited 2019-06-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 7
PDB declaration: nonameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
ZN ZINC ION × 1
SF4 IRON/SULFUR CLUSTER × 1
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.10 Å
|
|
6TNY
Processive human polymerase delta holoenzyme
Deposited 2019-12-10
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 7
PDB declaration: nonameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
ZN ZINC ION × 1
SF4 IRON/SULFUR CLUSTER × 1
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.08 Å
|
|
6TNZ
Human polymerase delta-FEN1-PCNA toolbelt
Deposited 2019-12-10
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
ZN ZINC ION × 1
SF4 IRON/SULFUR CLUSTER × 1
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.05 Å
|
|
6VVO
Structure of the human clamp loader (Replication Factor C, RFC) bound to the sliding clamp (Proliferating Cell Nuclear Antigen, PCNA)
Deposited 2020-02-18
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
7EFA
Crystal structure of the complex between the C-terminal domain of mouse MUTYH and human PCNA
Deposited 2021-03-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG8000, imidazole
|
Resolution 2.70 Å
R-free 0.286
|
|
7KQ0
PCNA bound to peptide mimetic
Deposited 2020-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–259(259 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M magnesium acetate, 20% poly(ethylene) glycol 3350
|
Resolution 2.40 Å
R-free 0.201
|
|
7KQ0
PCNA bound to peptide mimetic
Deposited 2020-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–259(259 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M magnesium acetate, 20% poly(ethylene) glycol 3350
|
Resolution 2.40 Å
R-free 0.201
|
|
7KQ0
PCNA bound to peptide mimetic
Deposited 2020-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
1–259(259 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M magnesium acetate, 20% poly(ethylene) glycol 3350
|
Resolution 2.40 Å
R-free 0.201
|
|
7KQ1
PCNA bound to truncated peptide mimetic
Deposited 2020-11-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–259(259 aa)
Chain C
1–259(259 aa)
Chain E
1–259(259 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289.15 K;0.1M sodium malonate and 8% poly(ethylene)glycol 3350
|
Resolution 3.30 Å
R-free 0.267
|
|
7M5L
PCNA bound to peptide mimetic with linker
Deposited 2021-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–258(258 aa)
Chain B
1–258(258 aa)
Chain C
1–258(258 aa)
|
Not recorded
|
TME PROPANE × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M magnesium acetate, 19.2% poly(ethylene) glycol 3350
|
Resolution 3.00 Å
R-free 0.275
|
|
7M5M
PCNA bound to peptide mimetic
Deposited 2021-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–259(259 aa)
Chain B
1–259(259 aa)
Chain C
1–259(259 aa)
|
Not recorded
|
NBU N-BUTANE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M Magnesium acetate, 19.5% poly(ethylene) glycol 3350
|
Resolution 3.00 Å
R-free 0.274
|
|
7M5N
PCNA bound to peptide mimetic with linker
Deposited 2021-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–259(259 aa)
Chain B
1–259(259 aa)
Chain C
1–259(259 aa)
|
Not recorded
|
8VH 1,3-dimethylbenzene × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293.15 K;0.18M magnesium acetate, 19.3% poly(ethylene) glycol 3350
|
Resolution 3.11 Å
R-free 0.309
|
|
7NV0
Human Pol Kappa holoenzyme with wt PCNA
Deposited 2021-03-15
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
7NV1
Human Pol Kappa holoenzyme with Ub-PCNA
Deposited 2021-03-15
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.40 Å
|
|
7QNZ
human Lig1-DNA-PCNA complex reconstituted in absence of ATP
Deposited 2021-12-23
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: heptameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.58 Å
|
|
7QO1
complex of DNA ligase I and FEN1 on PCNA and DNA
Deposited 2021-12-23
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 5
PDB declaration: octameric
|
Chain B
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.40 Å
|
|
8B8T
Open conformation of the complex of DNA ligase I on PCNA and DNA in the presence of ATP
Deposited 2022-10-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–255(255 aa)
Chain F
1–255(255 aa)
Chain G
1–255(255 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å
|
|
8COB
Crystal structure of human PCNA in complex with ERCC6L2 PIP box peptide
Deposited 2023-02-27
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;25% (w/v) PEG3350, 100 mM BIS-TRIS pH 5.5
|
Resolution 2.73 Å
R-free 0.255
|
|
8E84
Human PCNA mutant- C148S
Deposited 2022-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–261(261 aa)
|
Mutation:C148S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;175 mM Magnesium Acetate, 20% PEG 3350
|
Resolution 3.10 Å
R-free 0.292
|
|
8E84
Human PCNA mutant- C148S
Deposited 2022-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–261(261 aa)
|
Mutation:C148S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;175 mM Magnesium Acetate, 20% PEG 3350
|
Resolution 3.10 Å
R-free 0.292
|
|
8E84
Human PCNA mutant- C148S
Deposited 2022-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–261(261 aa)
|
Mutation:C148S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;175 mM Magnesium Acetate, 20% PEG 3350
|
Resolution 3.10 Å
R-free 0.292
|
|
8F5Q
Crystal structure of human PCNA in complex with the PIP box of FBH1
Deposited 2022-11-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–259(259 aa)
Chain C
1–259(259 aa)
Chain E
1–259(259 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.1 M HEPES, pH 7.5, 0.2 M magnesium chloride, 30% PEG400
|
Resolution 1.90 Å
R-free 0.266
|
|
8GCJ
PCNA
Deposited 2023-03-01
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain C
1–261(261 aa)
Chain E
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289.15 K;0.2 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350
|
Resolution 2.85 Å
R-free 0.278
|
|
8GCJ
PCNA
Deposited 2023-03-01
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–261(261 aa)
Chain D
1–261(261 aa)
Chain F
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289.15 K;0.2 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350
|
Resolution 2.85 Å
R-free 0.278
|
|
8GL9
Co-crystal structure of caPCNA bound to AOH1160 derivative 1LE
Deposited 2023-03-21
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
CL CHLORIDE ION × 6
ZQW N~2~-(naphthalene-1-carbonyl)-N-(2-phenoxyphenyl)-L-alpha-glutamine × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M sodium cacodylate, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
Resolution 2.81 Å
R-free 0.240
|
|
8GL9
Co-crystal structure of caPCNA bound to AOH1160 derivative 1LE
Deposited 2023-03-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–261(261 aa)
|
Not recorded
|
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M sodium cacodylate, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
Resolution 2.81 Å
R-free 0.240
|
|
8GLA
Co-crystal structure of caPCNA bound to the AOH1996 derivative, AOH1996-1LE
Deposited 2023-03-21
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
ZQZ N-[2-(3-methoxyphenoxy)phenyl]-N~2~-(naphthalene-1-carbonyl)-L-alpha-glutamine × 6
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
Resolution 3.77 Å
R-free 0.260
|
|
8GLA
Co-crystal structure of caPCNA bound to the AOH1996 derivative, AOH1996-1LE
Deposited 2023-03-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–261(261 aa)
|
Not recorded
|
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M sodium cacodylate pH 6.5, 0.2 M sodium chloride, 2.0 M ammonium sulfate
|
Resolution 3.77 Å
R-free 0.260
|
|
8UI7
Cryo-EM map of human clmap-clamp loader ATAD5-RFC-gapped PCNA complex in intermediate state 3
Deposited 2023-10-10
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 3
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å
|
|
8UI8
Cryo-EM map of human clamp-clamp loader ATAD5-RFC-two PCNAs complex in intermediate state 3
Deposited 2023-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 3
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8UI9
Cryo-EM map of human clamp-clamp loader ATAD5-RFC-cracked PCNA complex in intermediate state 2
Deposited 2023-10-10
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
8UII
Cryo-EM map of human clamp-clamp loader ATAD5-RFC-closed PCNA complex in intermediate state 1
Deposited 2023-10-10
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.04 Å
|
|
8UMT
Atomic model of the human CTF18-RFC-PCNA binary complex in the three-subunit binding state (state 2)
Deposited 2023-10-18
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 3
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.33 Å
|
|
8UMU
Atomic model of the human CTF18-RFC-PCNA binary complex in the four-subunit binding state (state 3)
Deposited 2023-10-18
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 3
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.16 Å
|
|
8UMV
Atomic model of the human CTF18-RFC-PCNA-DNA ternary complex with narrow PCNA opening state I (state 5)
Deposited 2023-10-18
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.75 Å
|
|
8UMW
Atomic model of the human CTF18-RFC-PCNA-DNA ternary complex in the five-subunit binding state (state 4)
Deposited 2023-10-18
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.93 Å
|
|
8UMY
Atomic model of the human CTF18-RFC-PCNA-DNA ternary complex with narrow PCNA opening state II (state 6)
Deposited 2023-10-18
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.83 Å
|
|
8UN0
Atomic model of the human CTF18-RFC-PCNA-DNA ternary complex with cracked and closed PCNA (state 7)
Deposited 2023-10-18
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 8
PDB declaration: decameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8YJH
Structure of the human endogenous PCNA-FEN1 complex - State A
Deposited 2024-03-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.68 Å
|
|
8YJL
Structure of the human endogenous PCNA-FEN1 complex - State B
Deposited 2024-03-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.51 Å
|
|
8YJQ
Structure of the human endogenous PCNA-FEN1 complex - State C
Deposited 2024-03-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.51 Å
|
|
8YJR
Structure of the human endogenous PCNA-FEN1 complex - State D
Deposited 2024-03-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.51 Å
|
|
8YJS
Structure of the human endogenous PCNA-FEN1 complex - State E
Deposited 2024-03-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.55 Å
|
|
8YJU
Structure of the human endogenous PCNA-FEN1 complex - State F
Deposited 2024-03-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.78 Å
|
|
8YJV
Structure of the human endogenous PCNA-FEN1 complex - State G
Deposited 2024-03-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.51 Å
|
|
8YJW
Structure of the human endogenous PCNA-FEN1 complex - State H
Deposited 2024-03-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: octameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.55 Å
|
|
8YJZ
Structure of the human endogenous PCNA-FEN1-RNase H2 complex - State D
Deposited 2024-03-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 7
PDB declaration: decameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.15 Å
|
|
8ZWO
Structure of CTF18-PCNA with ATP
Deposited 2024-06-13
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
Chain H
1–261(261 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 3
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris-HCl, 200 mM NaCl, 1 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.99 Å
|
|
9B8S
Human polymerase epsilon bound to PCNA and DNA in the nucleotide exchange state
Deposited 2024-03-31
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.01 Å
|
|
9B8T
Human polymerase epsilon bound to PCNA and DNA in the nucleotide bound state
Deposited 2024-03-31
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
TTP THYMIDINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.95 Å
|
|
9CG4
Cryo-EM structure of FAN1, PCNA and DNA substrate with (CAG)2 extrusion in intermediate state
Deposited 2024-06-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.37 Å
|
|
9CHM
Cryo-EM structure of FAN1 R507H and PCNA in intermediate state
Deposited 2024-07-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å
|
|
9CL7
Cryo-EM structure of FAN1-PCNA-DNA in final state
Deposited 2024-07-10
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.83 Å
|
|
9CMA
Cryo-EM structure of FAN1 R507H-PCNA-DNA in final state
Deposited 2024-07-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.97 Å
|
|
9EOA
Cryo_EM structure of human FAN1 in complex with 5' flap DNA substrate and PCNA
Deposited 2024-03-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: heptameric
|
Chain F
1–256(256 aa)
Chain G
1–256(256 aa)
Chain H
1–256(256 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.27 Å
|
|
9F6D
Human DNA polymerase epsilon bound to DNA and PCNA (open conformation)
Deposited 2024-05-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
DDS 2',3'-dideoxyadenosine triphosphate × 1
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9F6E
Human DNA polymerase epsilon bound to DNA and PCNA (ajar conformation)
Deposited 2024-05-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
DDS 2',3'-dideoxyadenosine triphosphate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.74 Å
|
|
9F6F
Human DNA polymerase epsilon bound to DNA and PCNA (closed conformation)
Deposited 2024-05-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
DDS 2',3'-dideoxyadenosine triphosphate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.75 Å
|
|
9GY0
Cryo_EM structure of human FAN1 R507H mutant in complex with 5' flap DNA substrate and PCNA
Deposited 2024-10-01
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: heptameric
|
Chain E
1–261(261 aa)
Chain F
1–261(261 aa)
Chain G
1–261(261 aa)
|
Not recorded
|
CA CALCIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.42 Å
|
|
9N3L
Co-crystal structure of PCNA bound to HSP90alpha inhibitor, SNX2112
Deposited 2025-01-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–261(261 aa)
|
Not recorded
|
E0G 4-[6,6-dimethyl-4-oxidanylidene-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-oxidanylcyclohexyl)amino]benzamide × 3
CL CHLORIDE ION × 6
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M sodium cacodylate pH 6.5, 0.2M sodium chloride, 2.0M ammonium sulfate
|
Resolution 1.90 Å
R-free 0.233
|
|
9NE6
Human polymerase epsilon bound to PCNA and DNA with an in-situ-generated mismatch in the mismatch-editing state
Deposited 2025-02-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.11 Å
|
|
9NE7
Human polymerase epsilon bound to PCNA and DNA with an in-situ-generated mismatch in the Pol-backtracking state
Deposited 2025-02-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.53 Å
|
|
9NE8
Human polymerase epsilon bound to PCNA and DNA with an in-situ-generated mismatch in the mismatch-locking state
Deposited 2025-02-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9NE9
Human polymerase epsilon bound to PCNA and DNA with a pre-existing mismatch in the blocked conformation I
Deposited 2025-02-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.88 Å
|
|
9NEA
Human polymerase epsilon bound to PCNA and DNA with a pre-existing mismatch in the blocked conformation II
Deposited 2025-02-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.81 Å
|
|
9SRI
Human DNA polymerase epsilon bound to DNA blunt end
Deposited 2025-09-24
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
Chain D
1–261(261 aa)
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.6
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
9UIQ
Structure of CTF18-PCNA with ATP
Deposited 2025-04-16
|
Different construct
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
1–257(257 aa)
Chain G
1–257(257 aa)
Chain H
1–257(257 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 3
MG MAGNESIUM ION × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;50 mM Tris-HCl, 200 mM NaCl, 1 mM DTT
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9VGW
Crystal structure of human PCNA in complex with REV1 PIP-box
Deposited 2025-06-15
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–261(261 aa)
Chain B
1–261(261 aa)
Chain C
1–261(261 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;ammonium sulfate
|
Resolution 2.70 Å
R-free 0.261
|